These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11843466)

  • 41. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intraprocedural use of ibutilide to organize and guide ablation of complex fractionated atrial electrograms: preliminary assessment of a modified step-wise approach to ablation of persistent atrial fibrillation.
    Singh SM; D'Avila A; Kim SJ; Houghtaling C; Dukkipati SR; Reddy VY
    J Cardiovasc Electrophysiol; 2010 Jun; 21(6):608-16. PubMed ID: 20039991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical evaluation in therapy of patients with atrial fibrillation or flutter.
    Waldo AL
    Cardiol Clin; 1990 Aug; 8(3):479-90. PubMed ID: 2205386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
    Singh SN; Tang XC; Reda D; Singh BN
    Heart Rhythm; 2009 Feb; 6(2):152-5. PubMed ID: 19187902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors for recurrence of atrial fibrillation in patients undergoing hybrid therapy for antiarrhythmic drug-induced atrial flutter.
    Reithmann C; Dorwarth U; Dugas M; Hahnefeld A; Ramamurthy S; Remp T; Steinbeck G; Hoffmann E
    Eur Heart J; 2003 Jul; 24(13):1264-72. PubMed ID: 12831821
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of atrial fibrillation and atrial flutter: Part II.
    Aronow WS
    Cardiol Rev; 2008; 16(5):230-9. PubMed ID: 18708824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation.
    Stabile G; De Simone A; Turco P; La Rocca V; Nocerino P; Astarita C; Maresca F; De Matteis C; Di Napoli T; Stabile E; Vitale DF
    J Am Coll Cardiol; 2001 May; 37(6):1639-44. PubMed ID: 11345378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation.
    Schumacher B; Jung W; Lewalter T; Vahlhaus C; Wolpert C; Lüderitz B
    Am J Cardiol; 1999 Mar; 83(5):710-3. PubMed ID: 10080423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Non-pharmacologic treatment of atrial fibrillation].
    Csanádi Z; Fazekas T; Varró A
    Orv Hetil; 2003 Jun; 144(26):1279-89. PubMed ID: 12894672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm and amiodarone.
    Van Noord T; Van Gelder IC; Schoonderwoerd BA; Crijns HJ
    Am J Cardiol; 2000 Dec; 86(12):1384-5, A5. PubMed ID: 11113420
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amiodarone reduces the amount of ablation during catheter ablation for persistent atrial fibrillation.
    Miwa Y; Minamiguchi H; Bhandari AK; Cannom DS; Ho IC
    Europace; 2014 Jul; 16(7):1007-14. PubMed ID: 24446509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Resistant atrial fibrillation: how far does one go in its treatment?].
    Verbeet T
    Rev Med Brux; 1999 Sep; 20(4):A237-44. PubMed ID: 10523899
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of drugs for cardioversion of recent onset atrial fibrillation and flutter. Focus on ibutilide.
    Obel OA; Camm AJ
    Drugs Aging; 1998 Jun; 12(6):461-76. PubMed ID: 9638394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.
    Howard PA
    Ann Pharmacother; 1999 Jan; 33(1):38-47. PubMed ID: 9972384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Atrial Fibrillation: How Important is Rhythm Control Therapy?].
    Meyer C; Metzner A; Kirchhof P
    Dtsch Med Wochenschr; 2020 Apr; 145(8):543-549. PubMed ID: 32294780
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.
    Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G
    Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atrial fibrillation: insights from clinical trials and novel treatment options.
    Blaauw Y; Crijns HJ
    J Intern Med; 2007 Dec; 262(6):593-614. PubMed ID: 18028181
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Can short-term verapamil therapy reduce the recurrence of atrial fibrillation after successful low energy intracardiac cardioversion?
    Zardo F; Antonini-Canterin F; Brieda M; Hrovatin E; Pavan D; Burelli C; Cervesato E; Nicolosi GL
    Ital Heart J; 2001 Jul; 2(7):513-8. PubMed ID: 11501960
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How to enhance acute outcome of electrical cardioversion by drug therapy: importance of immediate reinitiation of atrial fibrillation.
    Van Noord T; Van Gelder IC; Crijns HJ
    J Cardiovasc Electrophysiol; 2002 Aug; 13(8):822-5. PubMed ID: 12212706
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiofrequency ablation of paroxysmal atrial fibrillation: factors determining long-term clinical efficacy.
    Sartini RJ; Scanavacca MI; Sosa E; Moreira LF; Lara S; Hardy C; Darrieux F; Hachul D
    Arq Bras Cardiol; 2008 Feb; 90(2):112-8. PubMed ID: 18392383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.